New
Kuniz Tablet (Apremilast) 30mg
Kuniz Tablet (Apremilast) 30mg
Kuniz Tablet (Apremilast) 30mg
Description
Targeted Oral Therapy for Psoriasis & Psoriatic Arthritis
Kuniz Tablet 30 mg contains the active ingredient Apremilast, a phosphodiesterase 4 (PDE4) inhibitor that helps regulate inflammatory signalling in the body.
It is used in adults for treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis, particularly in cases where other systemic therapies are insufficient or not tolerated.
By increasing intracellular cyclic AMP levels, Apremilast helps reduce pro-inflammatory cytokines, leading to decreased skin lesion severity, fewer plaques and reduced joint inflammation.


